Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142397 Genetically engineering cell; obtain cell, incubate with cell growth factor, remove nucleus or chromatin, insert into cell, propagate cell
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142374 Generating genetically engineered antibody with expanded half-life; obtain nucleotide sequences, insert segment coding preferential immunoglobulin fragment, recover protein
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142283 Inhibitors of C-reactive protein induced inflammation
10/03/2002US20020142282 Immortalized human keratinocyte cell line
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142025 Mixture of proteins, carbohydrates, methionine, cysteine, folic acid, pyridoxal and zinc
10/03/2002US20020142012 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020141972 Administering protein and antiinflection agent
10/03/2002US20020141956 Skin whiteners containing hydroxytetronic acid derivatives
10/03/2002US20020141946 Formulation of dipalmitoylphosphatidyl choline (DPPC), insulin and sodium citrate
10/03/2002CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
10/03/2002CA2442576A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002CA2442280A1 A stable pharmaceutical composition of pravastatin
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442080A1 A preparation for restenosis prevention
10/03/2002CA2442012A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002CA2442003A1 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441926A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002CA2441889A1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441412A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441377A1 Protein phosphate inhibitors
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2441201A1 Thrombin and anhydrothrombin with modified carboxyl groups
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2440322A1 Oligonucleotide conjugates
10/03/2002CA2439676A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245572A1 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245565A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244702A2 A process for isolation of osteopontin from milk
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244667A2 Cyclohexene nucleic acids
10/02/2002EP1244662A1 Compound and method for the treatment of pain
10/02/2002EP1244659A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244650A1 Arylamine derivatives and their use as anti-telomerase agent
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244498A2 Combination of trimebutine with an opioid analgesic
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1564